Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 30821-30830 Newer>

The Motley Fool June 27, 2008 Rich Smith	GE: Not Too Big to Bounce At GE, all six of the company's major divisions pull their own weight -- and they rake in operating margins in the mid-teens or higher.
The Motley Fool June 27, 2008 David Lee Smith	Recession-Proof Stocks: Diamond Offshore This deepwater driller taps a great combination of growth and income.
The Motley Fool June 27, 2008 Philip Durell	Recession-Proof Stocks: Paychex Paychex plays second banana to industry giant Automatic Data Processing, but that gives the company more room to grow.
The Motley Fool June 27, 2008 Rick Aristotle Munarriz	Recession-Proof Stocks: Hasbro When it comes to bouncing back, Hasbro is the Superball of toymakers.
The Motley Fool June 27, 2008 Ryan Fuhrmann	Recession-Proof Stocks: Johnson & Johnson This industry titan's stock is beaten down and should recover quite nicely when headwinds stop working against it and start to shift toward its back.
The Motley Fool June 27, 2008 Brian Lawler	This Drug Market Is Booming One therapeutic category seems to be expanding significantly faster than most of its peers, the one that helps the unfortunately burgeoning number of diabetics in the U.S. and worldwide.
The Motley Fool June 27, 2008 Joe Magyer	9 Recession-Proof Stocks The stock market? Hurting. Home values? Plunging. Consumer confidence? At a 16-year low. Oil prices? You don't even want to know. So what's an investor to do? Think big. Big brands. Big moats. Big dividends.
The Motley Fool June 26, 2008 Rich Smith	Fool on Call: AeroVironment Rides the Rocket AeroVironment management was as good as its word this quarter, reporting a sales increase of 24%, and gross margins of 36% on those sales.
The Motley Fool June 26, 2008 Anders Bylund	A Red Hat Packed With Dynamite Red Hat's Linux is still mostly a geek's dream, but its mainstream explosion is coming.
The Motley Fool June 26, 2008 Brian Lawler	Gauging Glaxo's Vaccine Value Surprise! The FDA actually approves Glaxo's new combination children's vaccine without delay.
<Older 30821-30830 Newer> Return to current articles.